CH602755A5CH1033477ACH1033477ACH602755A5CH 602755 A5CH602755 A5CH 602755A5CH 1033477 ACH1033477 ACH 1033477ACH 1033477 ACH1033477 ACH 1033477ACH 602755 A5CH602755 A5CH 602755A5
Authority
CH
Switzerland
Application number
CH1033477A
Inventor
Takashi Kamiya
Tsutomu Teraji
Masashi Hashimoto
Osamu Nakaguti
Teruo Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48030719Aexternal-prioritypatent/JPS5932472B2/ja
Priority claimed from JP3071873Aexternal-prioritypatent/JPS5930715B2/ja
Priority claimed from JP8785273Aexternal-prioritypatent/JPS5036485A/ja
Priority claimed from JP8785373Aexternal-prioritypatent/JPS5036486A/ja
Application filed by Fujisawa Pharmaceutical CofiledCriticalFujisawa Pharmaceutical Co
Publication of CH602755A5publicationCriticalpatent/CH602755A5/xx
C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring